24 May 2013
Keywords: norgine, appoints, gsk, stuart, dollow, senior, position
Article | 27 October 2008
UK-based Norgine has appointed Stuart Dollow as chief development officer, effective January 1, 2009. Dr Dollow joins the company from
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 October 2008
23 May 2013
© 2013 thepharmaletter.com